SG Americas Securities
ARLZ

SG Americas Securities’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

SG Americas Securities’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,586
Closed -$24K – 3964
2017
Q3 		$24K Buy
+10,586
New +$14.2K ﹤0.01% 3398
2017
Q2 		– Sell
-12,126
Closed -$26K – 3798
2017
Q1 		$26K Sell
12,126
-9,892
-45% -$37.2K ﹤0.01% 3172
2016
Q4 		$97K Buy
+22,018
New +$105K ﹤0.01% 2880

Other funds holding ARLZ

PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BMCM
Bryn Mawr Capital Management Philadelphia, Pennsylvania $2.06B AUM 19.82% 1-Year Est. Return

SG Americas Securities's ARLZ Position: Q4 2017 in Review

SG Americas Securities sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q4 2017, closing a stake of 10,586 shares — an estimated $24K sold.

SG Americas Securities first reported a position in ARLZ in Q4 2016 and held it in 3 quarters. The position peaked at $97K in Q4 2016. 63 funds tracked by Wall St. Rank hold ARLZ as of Q4 2017.

  • SG Americas Securities reported no remaining Aralez Pharmaceuticals Inc. position as of Q4 2017 after selling out during the quarter.
  • SG Americas Securities sold 10,586 Aralez Pharmaceuticals Inc. shares in Q4 2017, an estimated $24K.
  • SG Americas Securities first reported a position in Aralez Pharmaceuticals Inc. in Q4 2016 and held it in 3 quarters.
  • SG Americas Securities's Aralez Pharmaceuticals Inc. position peaked at $97K in Q4 2016.
  • 63 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q4 2017.

Based on SG Americas Securities's 13F filing for Q4 2017, filed 24 Jan 2018.